Jubilant Pharma And Chemical Lab (Opc) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-07-2024
- Paid Up Capital ₹ 5.00 M
as on 16-07-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.08 Cr
as on 16-07-2024
- Revenue 26.19%
(FY 2023)
- Profit 56.12%
(FY 2023)
- Ebitda 36.42%
(FY 2023)
- Net Worth 43.99%
(FY 2023)
- Total Assets 33.95%
(FY 2023)
About Jubilant Pharma And Chemical Lab (Opc)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹20.08 Cr.
Madhuri Deshmukh serves as a director at the Company.
- CIN/LLPIN
U74120MH2016OPC272308
- Company No.
272308
- Incorporation Date
22 Jan 2016
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jubilant Pharma And Chemical Lab (Opc) Private Limited offer?
Jubilant Pharma And Chemical Lab (Opc) Private Limited offers a wide range of products and services, including Repair & Maintenance Services, Plant Maintenance Services, Pharma & Bioanalytical Services, Pharmaceutical Testing Services, Material Testing Labs & Services, Testing Services, Electrical Testing Service, Agricultural & Farm Consultants, Agricultural Testing Service, Inspection & Quality Check Services.
Who are the key members and board of directors at Jubilant Pharma And Chemical Lab (Opc)?
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhuri Deshmukh  | Director | 22-Jan-2016 | Current |
Financial Performance of Jubilant Pharma And Chemical Lab (Opc).
Jubilant Pharma And Chemical Lab (Opc) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.19% increase. The company also saw a substantial improvement in profitability, with a 56.12% increase in profit. The company's net worth Soared by an impressive increase of 43.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jubilant Pharma And Chemical Lab (Opc)?
In 2023, Jubilant Pharma And Chemical Lab (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Mar 2023 | ₹14.65 Cr | Open |
Others Creation Date: 12 Aug 2020 | ₹8.50 M | Open |
Others Creation Date: 11 Aug 2020 | ₹6.40 M | Open |
How Many Employees Work at Jubilant Pharma And Chemical Lab (Opc)?
Jubilant Pharma And Chemical Lab (Opc) has a workforce of 72 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jubilant Pharma And Chemical Lab (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Pharma And Chemical Lab (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
